Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Dexmedetomidine As Myocardial Protection In Pediatric Cyanotic Congenital Heart Disease Undergoing Open Cardiac Surgery Using Cardiopulmonary Bypass Machine: A Preliminary Study

NCT05300802 is registered in ClinicalTrials.gov with National Cardiovascular Center Harapan Kita Hospital Indonesia as lead sponsor.

NCT NCT05300802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05300802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Dexmedetomidine As Myocardial Protection In Pediatric Cyanotic Congenital Heart Disease Undergoing Open Cardiac Surgery Using Cardiopulmonary Bypass Machine: A Preliminary Study
Lead sponsor
National Cardiovascular Center Harapan Kita Hospital Indonesia
Phase
Phase 2/3
Overall status
Completed
Start date
December 16, 2021
Completion date
July 16, 2022
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiopulmonary bypass, congenital heart disease in children